PMA
P140026: ENROUTE TRANSCAROTID STENT SYSTEM
FDA PMA · Stent, carotid · Boston Scientific Corporation
Key facts
| PMA number | P140026 |
|---|---|
| Trade name | ENROUTE TRANSCAROTID STENT SYSTEM |
| Generic name | Stent, carotid |
| Applicant | Boston Scientific Corporation |
| Owner/operator | Boston Scientific Corporation |
| Product code | NIM |
| Approval date | May 18, 2015 |
| Docket number | 15M-1956 |
| Notice date | Jun 2, 2015 |
| Establishment registration | 3022627847 |
| FEI number | 3022627847 |
At a glance
- 10–99 Supplements
- Jan 8, 2026 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- 10–99 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: